Source notes

Cells need energy at the right place and moment, especially when demand rises suddenly. This paper explains how creatine and the enzyme creatine kinase help meet that challenge. Creatine can become phosphocreatine, a reserve that rapidly helps regenerate ATP, the molecule cells use to power work. The same system transfers energy between production sites and places that consume it. The authors report that supplementation increases total muscle creatine stores by roughly 5–20% in many people. That range describes changes in storage, not an equivalent percentage improvement in strength, recovery, or health.

The strongest biological explanation concerns energy buffering and transport in tissues with substantial or fluctuating needs, including muscle and brain. The paper also explores membrane protection, oxidative stress, and cell survival. Much of that wider evidence comes from laboratory models. A substance having an important normal function does not establish that extra intake benefits every person or treats every condition discussed.

How Does This Show Up in Real Life?

During repeated brief efforts, muscles need to regenerate ATP quickly rather than wait for slower energy production to catch up. The creatine system helps explain why studies of supplementation often focus on intermittent, high-intensity exercise and recovery between efforts. It also explains why creatine research extends beyond sport: nerve cells and other tissues face local energy demands too. However, a promising experiment protecting mouse brain tissue is different from a demonstrated benefit for a human patient. The authors propose several applications in older adults, pregnancy, infancy, and serious illness, but explicitly call for larger or controlled studies in important areas. Those proposals should remain proposals when interpreting this paper. It provides mechanistic context and evidence from selected studies, not a universal supplementation plan or proof of benefit across those groups.

The evidence spans cell experiments, animal models, and human studies of very different sizes and purposes. One dialysis example involved only five patients. The authors acknowledge the need for large, longer-term studies to support preventive benefits in healthy people. Effects on a laboratory marker or during supplementation also do not establish that a clinical benefit persists after supplementation stops.

This source is most useful for understanding the energy system behind creatine research. Its broader applications deserve evidence matched to each population and outcome. Confidence in the basic biology should be kept separate from confidence in a proposed treatment or preventive use.